Literature DB >> 28084524

Intraoperative nerve staining in nerve-sparing radical hysterectomy: a pilot study.

Xuyin Zhang1, Luoqi Jia1, Xiang Tao2, Jingxin Ding3, Keqin Hua4.   

Abstract

OBJECTIVE: To evaluate the feasibility and effectiveness of intraoperative nerve staining by modified leucomethylene blue (MLB).
METHODS: Animal experiment was performed to assure whether the tissues dyed blue by MLB were nerves with microscopic examination. Ten patients with cervical cancer were performed by nerve-sparing radical hysterectomy (NSRH) and nerve staining intraoperatively by MLB. The status of staining was recorded. The post-void residual urine volume after removing was measured by ultrasound. The time to post-void residual urine volume of less than 100 ml and the first defecation were recorded.
RESULTS: In animal experiment, the tissues dyed blue obviously showed abundant nerve fibers by microscopic examination. The minor nerves were dyed blue clearly in NSRH. The time to post-void residual urine volume of less than 100 ml after removal of the urethral catheter was 10.3 (7-13) days by records. The time to the first defecation was 67.7 (60-82) h.
CONCLUSION: Intraoperative nerve staining by MLB provided a new method for nerve location in NSRH. It was safe, effective and convenient.

Entities:  

Keywords:  Leucomethylene blue; Nerve staining; Nerve-sparing radical hysterectomy

Mesh:

Substances:

Year:  2017        PMID: 28084524     DOI: 10.1007/s00404-016-4284-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Identification and injury to the inferior hypogastric plexus in nerve-sparing radical hysterectomy.

Authors:  Lei Li; Yalan Bi; Leiming Wang; Xinxin Mao; Bernhard Kraemer; Jinghe Lang; Quancai Cui; Ming Wu
Journal:  Sci Rep       Date:  2019-09-13       Impact factor: 4.379

2.  Epineural Methylene Blue Injection May Aid Localization of Digital Nerves in Dupuytren's Surgery.

Authors:  Tamás Szabó; Viktória Kormos; Zoltán Rékási; Balázs Gaszner
Journal:  Eur Surg Res       Date:  2021-10-22       Impact factor: 1.114

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.